A detailed history of State Of Alaska, Department Of Revenue transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 9,467 shares of ANIP stock, worth $535,642. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,467
Previous 9,003 5.15%
Holding current value
$535,642
Previous $573,000 1.57%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$54.33 - $65.72 $25,209 - $30,494
464 Added 5.15%
9,467 $564,000
Q2 2024

Aug 05, 2024

SELL
$58.53 - $68.82 $10,593 - $12,456
-181 Reduced 1.97%
9,003 $573,000
Q1 2024

Apr 19, 2024

SELL
$54.2 - $69.69 $40,324 - $51,849
-744 Reduced 7.49%
9,184 $634,000
Q4 2023

Jan 19, 2024

SELL
$48.72 - $65.43 $2,289 - $3,075
-47 Reduced 0.47%
9,928 $547,000
Q3 2023

Oct 16, 2023

BUY
$50.28 - $64.61 $40,877 - $52,527
813 Added 8.87%
9,975 $579,000
Q2 2023

Jul 24, 2023

BUY
$37.29 - $53.83 $29,682 - $42,848
796 Added 9.51%
9,162 $493,000
Q1 2023

Apr 17, 2023

SELL
$37.61 - $45.72 $5,303 - $6,446
-141 Reduced 1.66%
8,366 $332,000
Q4 2022

Jan 11, 2023

BUY
$31.9 - $41.95 $4,721 - $6,208
148 Added 1.77%
8,507 $342,000
Q3 2022

Oct 20, 2022

SELL
$29.83 - $38.01 $24,072 - $30,674
-807 Reduced 8.8%
8,359 $268,000
Q2 2022

Jul 08, 2022

BUY
$23.09 - $33.46 $7,388 - $10,707
320 Added 3.62%
9,166 $271,000
Q1 2022

Apr 14, 2022

BUY
$26.91 - $47.15 $31,753 - $55,637
1,180 Added 15.39%
8,846 $248,000
Q4 2021

Jan 12, 2022

BUY
$32.97 - $56.85 $15,660 - $27,003
475 Added 6.61%
7,666 $353,000
Q3 2021

Oct 07, 2021

BUY
$26.48 - $35.99 $8,526 - $11,588
322 Added 4.69%
7,191 $236,000
Q2 2021

Jul 12, 2021

BUY
$31.86 - $38.6 $11,151 - $13,510
350 Added 5.37%
6,869 $240,000
Q1 2021

Apr 09, 2021

SELL
$28.4 - $36.14 $27,548 - $35,055
-970 Reduced 12.95%
6,519 $235,000
Q4 2020

Jan 08, 2021

SELL
$23.69 - $31.47 $34,658 - $46,040
-1,463 Reduced 16.34%
7,489 $217,000
Q3 2020

Oct 05, 2020

BUY
$26.38 - $33.1 $6,067 - $7,613
230 Added 2.64%
8,952 $252,000
Q2 2020

Jul 06, 2020

BUY
$29.93 - $50.1 $2,993 - $5,010
100 Added 1.16%
8,722 $282,000
Q1 2020

Apr 06, 2020

BUY
$30.35 - $67.14 $48,560 - $107,424
1,600 Added 22.79%
8,622 $351,000
Q4 2019

Jan 07, 2020

SELL
$55.65 - $79.83 $6,455 - $9,260
-116 Reduced 1.63%
7,022 $433,000
Q3 2019

Oct 02, 2019

BUY
$64.7 - $85.39 $276,721 - $365,213
4,277 Added 149.49%
7,138 $520,000
Q2 2019

Jul 23, 2019

BUY
$67.77 - $82.2 $4,540 - $5,507
67 Added 2.4%
2,861 $235,000
Q1 2019

Apr 09, 2019

BUY
$45.83 - $70.54 $1,604 - $2,468
35 Added 1.27%
2,794 $197,000
Q4 2018

Jan 10, 2019

SELL
$41.17 - $56.44 $8,645 - $11,852
-210 Reduced 7.07%
2,759 $124,000
Q2 2018

Jul 10, 2018

BUY
$56.38 - $68.08 $5,074 - $6,127
90 Added 3.13%
2,969 $198,000
Q1 2018

Apr 19, 2018

BUY
$56.98 - $72.41 $62,678 - $79,651
1,100 Added 61.83%
2,879 $167,000
Q3 2017

Oct 16, 2017

BUY
$43.46 - $52.49 $77,315 - $93,379
1,779
1,779 $93,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.